156 related articles for article (PubMed ID: 16176206)
1. The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003.
Eliasson B; Cederholm J; Nilsson P; Gudbjörnsdóttir S;
Diabet Med; 2005 Oct; 22(10):1420-6. PubMed ID: 16176206
[TBL] [Abstract][Full Text] [Related]
2. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.
Eliasson B; Eeg-Olofsson K; Cederholm J; Nilsson PM; Gudbjörnsdóttir S;
Diabetes Metab; 2007 Sep; 33(4):269-76. PubMed ID: 17499541
[TBL] [Abstract][Full Text] [Related]
3. The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.
Gudbjörnsdottir S; Cederholm J; Nilsson PM; Eliasson B;
Diabetes Care; 2003 Apr; 26(4):1270-6. PubMed ID: 12663609
[TBL] [Abstract][Full Text] [Related]
4. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.
Cederholm J; Eliasson B; Nilsson PM; Weiss L; Gudbjörnsdottir S;
Diabetes Res Clin Pract; 2005 Mar; 67(3):258-66. PubMed ID: 15713359
[TBL] [Abstract][Full Text] [Related]
5. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
[TBL] [Abstract][Full Text] [Related]
7. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
8. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
Davis TM; Cull CA; Holman RR;
Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
[TBL] [Abstract][Full Text] [Related]
9. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
[TBL] [Abstract][Full Text] [Related]
10. A diabetes scorecard does not improve HbA(1c), blood pressure, lipids, aspirin usage, exercise and diabetes knowledge over 9 months: a randomized controlled trial.
Irwig MS; Sood P; Ni D; Amass T; Khurana PS; Jayanthi VV; Wang L; Adler SM
Diabet Med; 2012 Sep; 29(9):1206-12. PubMed ID: 22332914
[TBL] [Abstract][Full Text] [Related]
11. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
[TBL] [Abstract][Full Text] [Related]
12. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
[TBL] [Abstract][Full Text] [Related]
13. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
[TBL] [Abstract][Full Text] [Related]
14. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
Torffvit O; Agardh CD
J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
[TBL] [Abstract][Full Text] [Related]
15. Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients.
Ascić-Buturović B; Kacila M; Kulić M
Bosn J Basic Med Sci; 2009 Feb; 9(1):44-8. PubMed ID: 19284394
[TBL] [Abstract][Full Text] [Related]
16. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
[TBL] [Abstract][Full Text] [Related]
17. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
Cook MN; Girman CJ; Stein PP; Alexander CM
Diabet Med; 2007 Apr; 24(4):350-8. PubMed ID: 17335466
[TBL] [Abstract][Full Text] [Related]
18. Diabetes guidelines: easier to preach than to practise?
Bryant W; Greenfield JR; Chisholm DJ; Campbell LV
Med J Aust; 2006 Sep; 185(6):305-9. PubMed ID: 16999670
[TBL] [Abstract][Full Text] [Related]
19. Microvascular complications and risk factors in patients with type 2 diabetes.
Del Cañizo Gómez FJ; Fernández Pérez C; Moreno Ruiz I; de Gorospe Pérez-Jáuregui C; Silveira Rodríguez B; González Losada T; Segura Galindo A
Endocrinol Nutr; 2011 Apr; 58(4):163-8. PubMed ID: 21411384
[TBL] [Abstract][Full Text] [Related]
20. Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes.
Yamanouchi T; Sakai T; Igarashi K; Ichiyanagi K; Watanabe H; Kawasaki T
Diabet Med; 2005 Aug; 22(8):980-5. PubMed ID: 16026361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
